Video

Emerging therapies in AMD management

Author(s):

OT Staff Reports

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

See more AMD Awareness content here, here, and here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Study highlights retinal vulnerability in patients with bipolar and depressive disorders
June 4th 2025

Study highlights retinal vulnerability in patients with bipolar and depressive disorders

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Ocular Therapeutix closes enrollment in phase 3 SOL-R clinical trial for wet AMD
June 2nd 2025

Ocular Therapeutix closes enrollment in phase 3 SOL-R clinical trial for wet AMD

EyePod podcast: Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)
November 1st 2024

Innovation Series: Expanding access to eye care, advice for aspiring innovators from DMEI ophthalmology residents (part 3)

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis
May 30th 2025

Q&A: Dilraj S. Grewal, MD, FASRS, on therapeutics for non-infectious uveitis

Strategic investment between Topcon and Pangaea
May 29th 2025

Strategic investment between Topcon and Pangaea

© 2025 MJH Life Sciences

All rights reserved.